Home » Topics » Conferences

Conferences
RSS

DPPE proves highly effective and well tolerated in metastatic breast cancer patients

June 30, 1998

No dose-limiting toxicity found yet for AN-9 in phase I

June 30, 1998

Hydroxyurea in combination regimens enhances anti-HIV activity

June 30, 1998

Early studies with JE-2147 yield promising results

June 30, 1998

Parke-Davis discusses development of potent, irreversible EGF receptor TK inhibitors

June 30, 1998

5alpha-Reductase inhibitor from Merck with potential in treating acne

June 30, 1998

TX-525, a potent synthetic progestin with low androgenic potential

June 30, 1998

Oxidized phenolic compounds with an unexpected mechanism of action

June 30, 1998

Various schedules and doses of DMDC explored in phase I

June 29, 1998

Pyrazoloacridine evaluated in patients with pancreatic and hepatobiliary cancer

June 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...